BR112022023512A2 - Ensaio baseado em crispr para a detecção de patógenos em amostras. - Google Patents

Ensaio baseado em crispr para a detecção de patógenos em amostras.

Info

Publication number
BR112022023512A2
BR112022023512A2 BR112022023512A BR112022023512A BR112022023512A2 BR 112022023512 A2 BR112022023512 A2 BR 112022023512A2 BR 112022023512 A BR112022023512 A BR 112022023512A BR 112022023512 A BR112022023512 A BR 112022023512A BR 112022023512 A2 BR112022023512 A2 BR 112022023512A2
Authority
BR
Brazil
Prior art keywords
pathogens
crispr
samples
detection
based assay
Prior art date
Application number
BR112022023512A
Other languages
English (en)
Inventor
Tony Hu Ye
Ning Bo
Huang Zhen
Original Assignee
The Administrators Of The Tulane Educational Fund
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Administrators Of The Tulane Educational Fund filed Critical The Administrators Of The Tulane Educational Fund
Publication of BR112022023512A2 publication Critical patent/BR112022023512A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/20Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

ENSAIO BASEADO EM CRISPR PARA A DETECÇÃO DE PATÓGENOS EM AMOSTRAS. A presente divulgação descreve um método para a detecção da presença de patógenos, incluindo SARS-CoV-2, em uma amostra. O método utiliza proteínas efetoras CRISPR junto com um RNA guia e uma molécula repórter. Os RNAs na amostra são primeiro opcionalmente extraídos e transcritos inversamente, seguido de amplificação, de tal modo que quando o RNA guia hibridiza com um fragmento de nucleotídeo alvo no DNA amplificado, a proteína efetora CRISPR cliva a molécula repórter, resultando em um sinal detectável.
BR112022023512A 2020-05-20 2021-05-20 Ensaio baseado em crispr para a detecção de patógenos em amostras. BR112022023512A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063027530P 2020-05-20 2020-05-20
PCT/US2021/033497 WO2021236987A2 (en) 2020-05-20 2021-05-20 Crispr-based assay for detecting pathogens in samples

Publications (1)

Publication Number Publication Date
BR112022023512A2 true BR112022023512A2 (pt) 2022-12-20

Family

ID=78707694

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022023512A BR112022023512A2 (pt) 2020-05-20 2021-05-20 Ensaio baseado em crispr para a detecção de patógenos em amostras.

Country Status (7)

Country Link
US (1) US20230183817A1 (pt)
EP (1) EP4153309A2 (pt)
JP (1) JP2023527145A (pt)
CN (1) CN116438299A (pt)
BR (1) BR112022023512A2 (pt)
MX (1) MX2022014399A (pt)
WO (1) WO2021236987A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114395636B (zh) * 2022-02-11 2024-04-23 南方医科大学 一种基于RPA-CRISPR/Cas12a的人型支原体检测系统及其应用
CN114717363A (zh) * 2022-06-09 2022-07-08 中国科学院深圳先进技术研究院 一种病原突变体的即时核酸检测方法及检测试剂盒
KR20240020320A (ko) * 2022-08-04 2024-02-15 한국생명공학연구원 SARS-CoV-2 RdRp 변이 육안 검출법
CN115807130A (zh) * 2022-11-16 2023-03-17 武汉大学 猴痘病毒快速检测方法
CN115651807B (zh) * 2022-11-18 2023-05-09 北京理工大学 核酸检测芯片和核酸检测方法
CN116479175A (zh) * 2023-03-13 2023-07-25 广州国家实验室 用于检测人副流感病毒核酸的检测系统、试剂盒及方法
CN117467804B (zh) * 2023-12-26 2024-04-02 丹娜(天津)生物科技股份有限公司 一种用于呼吸道合胞病毒核酸快速检测的引物及其应用
CN117604168A (zh) * 2024-01-19 2024-02-27 南京鸿明生物科技有限公司 一种免扩增的rna病毒基因组滴度测量方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070083945A1 (en) * 2000-03-10 2007-04-12 Byrum Joseph R Nucleic acid molecules and other molecules associated with plants
US7339051B2 (en) * 2003-04-28 2008-03-04 Isis Pharmaceuticals, Inc. Compositions and methods for the treatment of severe acute respiratory syndrome (SARS)
WO2017025984A1 (en) * 2015-08-07 2017-02-16 Council Of Scientific And Industrial Research Smartphone integrated real - time molecular diagnostic device
KR102587132B1 (ko) * 2016-03-04 2023-10-11 에디타스 메디신, 인코포레이티드 암 면역요법을 위한 crispr-cpf1-관련 방법, 조성물 및 구성성분

Also Published As

Publication number Publication date
CN116438299A (zh) 2023-07-14
EP4153309A2 (en) 2023-03-29
MX2022014399A (es) 2023-01-04
WO2021236987A2 (en) 2021-11-25
JP2023527145A (ja) 2023-06-27
US20230183817A1 (en) 2023-06-15
WO2021236987A3 (en) 2021-12-23

Similar Documents

Publication Publication Date Title
BR112022023512A2 (pt) Ensaio baseado em crispr para a detecção de patógenos em amostras.
ES2743050T3 (es) Composiciones y procedimientos para cuantificar una secuencia de ácido nucleico en una muestra
US10465236B2 (en) Nucleic acid detection method and kit
Jeong et al. Fluorometric detection of influenza viral RNA using graphene oxide
DE60143960D1 (de) Äuren
ATE546550T1 (de) Verfahren zum nachweis von hpv sowie sonden, primer und kits
EP3943614B1 (en) Novel probe set for isothermal one-pot reaction, and uses thereof
Wang et al. CRISPR-Cas13a cascade-based viral RNA assay for detecting SARS-CoV-2 and its mutations in clinical samples
US20120270216A1 (en) Compositions and methods for detecting and identifying salmonella enterica strains
BR112022015365A2 (pt) Ensaio baseado em crispr para detecção de tb em fluidos corporais
MX2022012074A (es) Métodos para la detección de bajos niveles del virus de la covid-19.
US20150093749A1 (en) Real-time pcr detection of streptococcus pyogenes
US8188257B1 (en) Direct quantification of ribosome inactivating protein
Quyen et al. Elimination of carryover contamination in real-time reverse transcriptase loop-mediated isothermal amplification for rapid detection of the SARS-CoV-2 virus in point-of-care testing
Fan et al. Loop-mediated isothermal amplification (LAMP)/Cas12a assay for detection of Ralstonia solanacearum in tomato
GB2401175A (en) Detection of SARS virus by PCR
ES2640570T3 (es) Ensayo de doble sonda para la detección de VHC
CN105256052B (zh) 一种用于军团菌快速检测与分型的试剂盒及其检测方法
Snow et al. Development of a widely applicable positive control strategy to support detection of infectious salmon anaemia virus (ISAV) using Taqman real‐time PCR
Yuan et al. Development of a reverse-transcription loop-mediated isothermal amplification method for detection of rabbit hemorrhagic disease virus
KR102435116B1 (ko) CRISPR-Cas 시스템과 멀티플렉스 LAMP 프라이머 세트를 이용한 인플루엔자 바이러스의 검출 방법
Arancia et al. Use of 65 kDa mannoprotein gene primers in real time PCR identification of Candida albicans in biological samples
CN103789447A (zh) 一种5’端tRNA半分子检测方法
Afolabi et al. Evaluation of genetic markers for forensic identification of human body fluids
Zhang et al. Current status of recombinase polymerase amplification technologies for the detection of pathogenic microorganisms